-
EP1165537
European procedure
Extract from the Register of European Patents
EP About this file: EP1165537
| EP1165537 - HYDROXYMATAIRESINOL IN CANCER PREVENTION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 28.11.2003 Database last updated on 30.07.2024 | Most recent event Tooltip | 26.11.2004 | Lapse of the patent in a contracting state | published on 12.01.2005 [2005/02] | Applicant(s) | For all designated states Hormos Nutraceutical Oy Ltd. Itäinen Pitkäkatu 4C Pharmacity 20520 Turku / FI | [2002/42] |
| Former [2002/01] | For all designated states Hormos Nutraceutical Oy Ltd. Tykistökatu 6A 20520 Turku / FI | Inventor(s) | 01 /
AHOTUPA, Markku Karjakuja 82 FIN-20540 Turku / FI | 02 /
ECKERMAN, Christer Itäharjunkatu 12 FIN-20540 Turku / FI | 03 /
KANGAS, Lauri Pasantie 3 B FIN-21280 Raisio / FI | 04 /
MÄKELÄ, Sari Metsäpirtinkatu 4 FIN-20740 Turku / FI | 05 /
SAARINEN, Niina Löytänänkatu 2 C 14 FIN-20540 Turku / FI | 06 /
SANTTI, Risto Mannerheiminkatu 23 FIN-21100 Naantali / FI | 07 /
WÄRRI, Anni Juhaninkuja 2 as 2 FIN-21420 Lieto / FI | [2002/01] | Representative(s) | Öhman, Ann-Marie Hormos Medical Corporation Itäinen Pitkäkatu 4 B 20520 Turku / FI | [N/P] |
| Former [2002/05] | Öhman, Ann-Marie Hormos Medical Corporation Itäinen Pitkäkatu 4 B 20520 Turku / FI | ||
| Former [2002/01] | Öhman, Ann-Marie c/o Hormos Medical Oy Ltd., Tykistökatu 6A 20520 Turku / FI | Application number, filing date | 00909388.1 | 09.03.2000 | [2002/01] | WO2000FI00181 | Priority number, date | US19990281094 | 30.03.1999 Original published format: US 281094 | [2002/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0059946 | Date: | 12.10.2000 | Language: | EN | [2000/41] | Type: | A1 Application with search report | No.: | EP1165537 | Date: | 02.01.2002 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.10.2000 takes the place of the publication of the European patent application. | [2002/01] | Type: | B1 Patent specification | No.: | EP1165537 | Date: | 22.01.2003 | Language: | EN | [2003/04] | Search report(s) | International search report - published on: | SE | 12.10.2000 | Classification | IPC: | C07D307/32, A61K31/00, A23L1/30 | [2002/01] | CPC: |
A61K31/365 (EP,US);
A61K31/341 (KR);
A23L33/105 (EP,US);
A61P1/00 (EP);
A61P13/00 (EP);
A61P13/02 (EP);
A61P13/08 (EP);
A61P13/10 (EP);
A61P15/00 (EP);
A61P15/08 (EP);
A61P25/00 (EP);
A61P35/00 (EP);
A61P39/06 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P5/30 (EP);
A61P5/32 (EP);
A61P9/00 (EP);
| C-Set: |
A23V2002/00, A23V2250/2132 (EP,US)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/01] | Extension states | AL | 20.08.2001 | LT | 20.08.2001 | LV | 20.08.2001 | MK | 20.08.2001 | RO | 20.08.2001 | SI | 20.08.2001 | Title | German: | HYDROXYMATAIRESINOL IN DER KREBS-PREVENTION | [2002/01] | English: | HYDROXYMATAIRESINOL IN CANCER PREVENTION | [2002/01] | French: | HYDROXYMATAIRESINOL EN PREVENTION ANTI-CANCEREUSE | [2002/01] | Entry into regional phase | 20.08.2001 | National basic fee paid | 20.08.2001 | Designation fee(s) paid | 20.08.2001 | Examination fee paid | Examination procedure | 28.08.2000 | Request for preliminary examination filed International Preliminary Examining Authority: SE | 20.08.2001 | Examination requested [2002/01] | 06.03.2002 | Despatch of a communication from the examining division (Time limit: M04) | 10.06.2002 | Reply to a communication from the examining division | 01.08.2002 | Communication of intention to grant the patent | 18.11.2002 | Fee for grant paid | 18.11.2002 | Fee for publishing/printing paid | Opposition(s) | 23.10.2003 | No opposition filed within time limit [2004/03] | Fees paid | Renewal fee | 20.03.2002 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 31.03.2003 | [2005/02] | Cited in | International search | [A]WO9714670 (KANOLDT ARZNEIMITTEL GMBH [DE], et al); | JP2000129256 [ ] (KADOYA SESAMI MILLS INC); | [XE] - KADOYA SEIYU K.K., "Antioxidants obtained from sesame seeds for pharmaceutical products and food additives", CHEMICAL ABSTRACTS, (2000), vol. 132, Database accession no. 310001, XP002933629 | [X] - GROSS ET AL., Plant Polyphenols 2: Chemistry, Biology, Pharmacology, Ecology, NEW YORK, KLUWER ACADEMIC/PLENUM PUBLISHERS, (1999), XP002933628 [X] * JOSHUA D. FORD et al.: "Plant ligands and health: Cancer chemoprevention and biotechnological opportunities; page 675 - page 694 * | [A] - JORMA MATTINEN ET AL., "NMR-spectroscopic study of hydroxymatairesinol, the major lignan in Norway spruce (picea abies) heartwood", MODELS IN CHEMISTRY, (1998), vol. 135, no. 4, pages 583 - 590, XP002933627 |